Unlearn.ai: an AI-driven innovation platform for clinical trials
Unlearn.ai is an artificial intelligence platform focused on pharmaceutical research and development. At its core, it utilizes historical patient data to create "digital twins" that serve as virtual controls in clinical trials, aiming to reduce the number of real control patients that need to be recruited, potentially accelerating the trial process, reducing costs and increasing trial efficiency. The technology is intended for pharmaceutical companies, biotechnology companies and clinical research organizations.